Allogene Therapeutics, Inc. (ALLO) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Allogene Therapeutics, Inc. (ALLO) closed at USD 1.34 on 2026-10-15, a change of +9.8 % over the past year, with a market capitalization of USD 452.59M.

Allogene Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Allogene Therapeutics, Inc. key figures

Previous close

USD 1.34 (2026-10-15)

1-year change

+9.8 %

Market cap

USD 452.59M

Enterprise value

USD 199M

P/E ratio (trailing)

-1.99

P/E ratio (forward)

-2.12

EPS (trailing)

-0.66

EPS (forward)

-0.62

PEG ratio

n/a

Price to book

1.04

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

9.71

Employees

150

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple allogeneic CAR T cell product candidates utilizing protein engineering, gene editing, gene insertion, and advanced proprietary T cell manufacturing technologies. The company is also developing cemacabtagene ansegedleucel (cema-cel), an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma (LBCL). In addition, it develops ALLO-316, an engineered allogeneic CAR T cell product candidate that targets CD70 to treat renal cell carcinoma (RCC); and ALLO-329, an engineered allogeneic CAR T cell product candidate that targets both CD19 and CD70 for the treatment of autoimmune diseases (AID), such as systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIM), and systemic sclerosis (SSc). The company was incorporated in 2017 and is headquartered in South San Francisco, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Allogene Therapeutics, Inc. and compare it with other stocks.